This is in agreement with those of Bugianesi et al. who reported significantly lower plasma adiponectin levels in patients with NAFLD as compared with healthy control subjects in Italy, but their study participants were mainly males [6]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.